Viewing Study NCT06518161


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-02-25 @ 9:48 PM
Study NCT ID: NCT06518161
Status: RECRUITING
Last Update Posted: 2025-05-14
First Post: 2024-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Development of an Atlas of Respiratory Host-microbiome Interactions in Healthy Volunteers
Sponsor: Nantes University Hospital
Organization:

Study Overview

Official Title: Développement d'un Atlas Des Interactions hôte-microbiome Respiratoire Chez Des Volontaires Sains
Status: RECRUITING
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HEALTHY LUNG
Brief Summary: The role of the pulmonary microbiome in the pathophysiology of lung disease is becoming increasingly well understood. Studies on murine models have highlighted the immunomodulatory and antibacterial activity of certain commensal bacteria, such as S. mitis, and have led to an understanding of their potential therapeutic impact. The investigators will therefore couple their analyses of the respiratory microbiome with an in-depth analysis of mucosal immunity. In particular, they will characterize immune cell types and frequencies using high-dimensional (spectral) flow cytometry and single cell RNA-sequencing. Finally, they will study the mediators exchanged between the microbiome and the host using proteomic and metabolomic analyses of respiratory fluids.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: